Fuller & Thaler Asset Management Inc. Has $117.92 Million Stock Position in Maximus, Inc. $MMS

Key Points

• Fuller & Thaler Asset Management Inc. has increased its stake in Maximus, Inc. by 40.0%, now owning about 3.06% of the company with shares valued at approximately $117.9 million.
• Maximus recently reported earnings of $2.16 EPS, exceeding analysts' expectations of $1.39, along with a revenue of $1.35 billion for the quarter.
• The company declared a quarterly dividend of $0.30 per share, representing an annualized yield of 1.4%, with the ex-dividend date set for August 15th.

Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 40.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,729,305 shares of the health services provider's stock after acquiring an additional 494,372 shares during the quarter. Fuller & Thaler Asset Management Inc. owned approximately 3.06% of Maximus worth $117,921,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Wellington Management Group LLP boosted its stake in shares of Maximus by 36.7% during the 1st quarter. Wellington Management Group LLP now owns 441,550 shares of the health services provider's stock worth $30,109,000 after acquiring an additional 118,503 shares during the period. Dimensional Fund Advisors LP boosted its stake in Maximus by 20.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock valued at $115,620,000 after purchasing an additional 288,990 shares during the period. Boston Partners bought a new stake in Maximus in the 1st quarter valued at $20,983,000. Caitong International Asset Management Co. Ltd boosted its stake in Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock valued at $36,000 after purchasing an additional 526 shares during the period. Finally, Russell Investments Group Ltd. boosted its stake in Maximus by 103.5% in the 1st quarter. Russell Investments Group Ltd. now owns 79,593 shares of the health services provider's stock valued at $5,427,000 after purchasing an additional 40,487 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

NYSE MMS traded up $1.5160 during midday trading on Friday, hitting $86.9260. The company had a trading volume of 517,681 shares, compared to its average volume of 569,834. The company has a market capitalization of $4.90 billion, a PE ratio of 16.01 and a beta of 0.60. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The firm has a 50-day moving average price of $74.16 and a 200-day moving average price of $70.99. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. The firm had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company's quarterly revenue was up 2.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus's payout ratio is currently 22.10%.

Insiders Place Their Bets

In other news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.